73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Combination immunotherapy produces high response rate in early results of trial targeting high-risk follicular lymphoma

Combination immunotherapy produces high response rate in early results of trial targeting high-risk follicular lymphoma

byUniversity of Miami Leonard M. Miller School of MedicineCancer cell during cell division. Credit: National Institutes of HealthResearchers conducting a Phase 2 clinical trial at Sylvester Comp

Combination immunotherapy produces high response rate in early results of trial targeting high-risk follicular lymphoma

byUniversity of Miami Leonard M. Miller School of MedicineCancer cell during cell division. Credit: National Institutes of HealthResearchers conducting a Phase 2 clinical trial at Sylvester Comp
As cancer treatment advances, patients and doctors push back against drugs' harsh side effects

As cancer treatment advances, patients and doctors push back against drugs' harsh side effects

by Carla K. JohnsonJill Feldman, 54, poses for a photo at her home in Deerfield, Ill., Friday, Jan. 19, 2024. Lung cancer patient and advocate Jill Feldman takes pills at home that shrink tumors by bl

As cancer treatment advances, patients and doctors push back against drugs' harsh side effects

by Carla K. JohnsonJill Feldman, 54, poses for a photo at her home in Deerfield, Ill., Friday, Jan. 19, 2024. Lung cancer patient and advocate Jill Feldman takes pills at home that shrink tumors by bl
Study describes treatment of secondary CNS involvement by aggressive lymphomas

Study describes treatment of secondary CNS involvement by aggressive lymphomas

by Sylvester Comprehensive Cancer CenterHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0Some patients with aggressive lymphomas

Study describes treatment of secondary CNS involvement by aggressive lymphomas

by Sylvester Comprehensive Cancer CenterHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0Some patients with aggressive lymphomas
Fewer cases of melanoma observed among people taking vitamin D supplements

Fewer cases of melanoma observed among people taking vitamin D supplements

byUniversity of Eastern FinlandCredit: Unsplash/CC0 Public DomainFewer cases of melanoma were observed among regular users of vitamin D supplements than among non-users, a new study finds. Peopl

Fewer cases of melanoma observed among people taking vitamin D supplements

byUniversity of Eastern FinlandCredit: Unsplash/CC0 Public DomainFewer cases of melanoma were observed among regular users of vitamin D supplements than among non-users, a new study finds. Peopl
Marijuana component offers opioid alternative by effectively treating dental pain

Marijuana component offers opioid alternative by effectively treating dental pain

by Andrew Smith,Rutgers UniversityCBD reduced the dental pain and increased the bite force in patients presented with emergency toothache. (A) Median visual analog scale (VAS) pain scores per ti

Marijuana component offers opioid alternative by effectively treating dental pain

by Andrew Smith,Rutgers UniversityCBD reduced the dental pain and increased the bite force in patients presented with emergency toothache. (A) Median visual analog scale (VAS) pain scores per ti
World-first clinical trial with 'man's best friend' could unlock treatment breakthrough for kids with cancer

World-first clinical trial with 'man's best friend' could unlock treatment breakthrough for kids with cancer

by Telethon Kids InstituteThree-year-old Bull Terrier, Maggie, is about to undergo surgery using the immunotherapy gel to treat her sarcoma. It is hoped the world-first clinical trial in dogs will be

World-first clinical trial with 'man's best friend' could unlock treatment breakthrough for kids with cancer

by Telethon Kids InstituteThree-year-old Bull Terrier, Maggie, is about to undergo surgery using the immunotherapy gel to treat her sarcoma. It is hoped the world-first clinical trial in dogs will be
Cancer cases will keep rising worldwide: Report

Cancer cases will keep rising worldwide: Report

by Dennis ThompsonCancer cases will continue to climb for the next two decades, spurred on by an aging worldwide population, a new report shows.An estimated 20 million new cancer cases were diagnosed

Cancer cases will keep rising worldwide: Report

by Dennis ThompsonCancer cases will continue to climb for the next two decades, spurred on by an aging worldwide population, a new report shows.An estimated 20 million new cancer cases were diagnosed
Identification of colony stimulating factor 1 receptor offers new strategy for cancer immunotherapy

Identification of colony stimulating factor 1 receptor offers new strategy for cancer immunotherapy

by Zhang Nannan,Chinese Academy of SciencesIHMT-CSF1R-833 alters the macrophage polarization in M2 macrophages derived from RAW264.7 cells by inducing the M1 macrophage phenotype. Credit: Liang

Identification of colony stimulating factor 1 receptor offers new strategy for cancer immunotherapy

by Zhang Nannan,Chinese Academy of SciencesIHMT-CSF1R-833 alters the macrophage polarization in M2 macrophages derived from RAW264.7 cells by inducing the M1 macrophage phenotype. Credit: Liang
Clinical trial shows significant disease-free survival for patients diagnosed with non-small cell lung cancer

Clinical trial shows significant disease-free survival for patients diagnosed with non-small cell lung cancer

byYale UniversityDFS per investigator assessment. Kaplan-Meier estimates of duration of (A) DFS in patients with stage II-IIIA disease and (B) in the overall population (stage IB-IIIA) by sevent

Clinical trial shows significant disease-free survival for patients diagnosed with non-small cell lung cancer

byYale UniversityDFS per investigator assessment. Kaplan-Meier estimates of duration of (A) DFS in patients with stage II-IIIA disease and (B) in the overall population (stage IB-IIIA) by sevent
Investigating the most allergen-inducing drugs

Investigating the most allergen-inducing drugs

by Scientific Project LomonosovComparison of % of spontaneous reports (SRs) with data on drug-induced anaphylaxis (SRsAs) due to a specific pharmacological group among the total SRsAs structure and %

Investigating the most allergen-inducing drugs

by Scientific Project LomonosovComparison of % of spontaneous reports (SRs) with data on drug-induced anaphylaxis (SRsAs) due to a specific pharmacological group among the total SRsAs structure and %
Team reports on development of potential new generic treatment for multiple types of cancer

Team reports on development of potential new generic treatment for multiple types of cancer

byRIKENA schematic of the study. The simple targeted alpha-particle therapy (TAT) compound was made by joining the radionuclide astatine-211 to an azide. The TAT compound was injected into a mic

Team reports on development of potential new generic treatment for multiple types of cancer

byRIKENA schematic of the study. The simple targeted alpha-particle therapy (TAT) compound was made by joining the radionuclide astatine-211 to an azide. The TAT compound was injected into a mic
New bone cancer drug improves survival rates by 50% in preclinical trials

New bone cancer drug improves survival rates by 50% in preclinical trials

byUniversity of East AngliaCredit: Pixabay/CC0 Public DomainResearchers at the University of East Anglia have developed a new drug that works against all of the main types of primary bone cancer

New bone cancer drug improves survival rates by 50% in preclinical trials

byUniversity of East AngliaCredit: Pixabay/CC0 Public DomainResearchers at the University of East Anglia have developed a new drug that works against all of the main types of primary bone cancer